Several reviews have confirmed that insomnia pathophysiology involves sleep deprivation-induced sympatho-adrenal activation, driving HPA axis hyperactivity characterized by elevated cortisol, corticotropin-releasing hormone (CRH) hypersecretion, and impaired glucocorticoid receptor feedback (27, 29). The gene discussed is CRH; the disease is insomnia measurement.